Cost Of New Drug Development Pushed To $2.6 Bil. By High Failure Rate – Study
This article was originally published in The Pink Sheet Daily
Executive Summary
The Tufts Centers for the Study of Drug Development updates its often-quoted drug development cost benchmark in a study released Nov. 18.